Home
PB Ratio of Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Ltd
NSE: WELCUREDRUGS
PB Ratio
Key Highlights
- The latest PB Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0.9.
- The PB ratio of the Welcure Drugs & Pharmaceuticals Ltd is below 1 which indicates that the stock is undervalued.
- The P/B Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 40 on March 2020 to 1 on March 2025 . This represents a CAGR of -45.93% over 6 years.
Historical P/B Ratio of Welcure Drugs & Pharmaceuticals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Welcure Drugs & Pharmaceuticals Ltd
Company Fundamentals for Welcure Drugs & Pharmaceuticals Ltd
Market Cap
94 Cr
EPS
2.5
P/E Ratio (TTM)
3.4
P/B Ratio (TTM)
0.9
Day’s High
8.78
Day’s Low
8.39
DTE
1.2
ROE
2.1
52 Week High
15.89
52 Week Low
6.4
ROCE
1.2
Market Price of Welcure Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
15 Sep 2025 | 8.39 |
12 Sep 2025 | 8.83 |
11 Sep 2025 | 9.29 |
10 Sep 2025 | 9.77 |
09 Sep 2025 | 10.28 |
08 Sep 2025 | 10.02 |
05 Sep 2025 | 9.81 |
04 Sep 2025 | 9.5 |
03 Sep 2025 | 9.22 |
02 Sep 2025 | 8.79 |
SWOT Analysis Of Welcure Drugs & Pharmaceuticals Ltd
BlinkX Score for Welcure Drugs & Pharmaceuticals Ltd
Asset Value vs Market Value of Welcure Drugs & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
Company | PB | Market Cap |
---|
Welcure Drugs & Pharmaceuticals Ltd | 0.92 | 94.4 |
Bharat Forge Ltd | 229.3 | 59168 |
AIA Engineering Ltd | 711.0 | 29331 |
PTC Industries Ltd | 887.9 | 21773 |
CIE Automotive India Ltd | 142.7 | 15372 |
Company | |
---|---|
Welcure Drugs & Pharmaceuticals Ltd | 0.92 |
Bharat Forge Ltd | 229.3 |
AIA Engineering Ltd | 711.0 |
PTC Industries Ltd | 887.9 |
CIE Automotive India Ltd | 142.7 |
PB Ratio of Welcure Drugs & Pharmaceuticals Ltd Explained
₹94.4
Market cap
₹9
Book Value per Share
0.9X
PB Ratio
Historical Market Cap of Welcure Drugs & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Welcure Drugs & Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Welcure Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Welcure Drugs & Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Welcure Drugs & Pharmaceuticals Ltd News Hub
Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.35 crore in the June 2024 quarter
Net Loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.35 crore in the quarter ended June 2024
Read more
14 Aug 24
Welcure Drugs & Pharmaceuticals to table results
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 A
Read more
09 Aug 24
Welcure Drugs & Pharmaceuticals to hold board meeting
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 Se
Read more
30 Aug 24
Welcure Drugs & Pharmaceuticals to conduct AGM
Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will
Read more
11 Sept 24